(Sharecast News) - Genedrive said on Tuesday that the University Hospitals Sussex NHS Foundation Trust had moved its MT-RNR1 test into routine clinical service for use in neonatal intensive care units.
The AIM-traded point-of-care pharmacogenetic testing company said the trust transitioned to business-as-usual clinical use of the Genedrive MT-RNR1 ID kit...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE